<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for pre-benefit 1440186878769 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_P53_PATHWAY'>HALLMARK_P53_PATHWAY</a></td><td><a href='HALLMARK_P53_PATHWAY.html'>Details ...</a></td><td>170</td><td>0.39</td><td>2.01</td><td>0.000</td><td>0.007</td><td>0.003</td><td>2571</td><td>tags=34%, list=18%, signal=41%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_TNFA_SIGNALING_VIA_NFKB'>HALLMARK_TNFA_SIGNALING_VIA_NFKB</a></td><td><a href='HALLMARK_TNFA_SIGNALING_VIA_NFKB.html'>Details ...</a></td><td>175</td><td>0.37</td><td>1.96</td><td>0.000</td><td>0.005</td><td>0.004</td><td>2757</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION'>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</a></td><td><a href='HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION.html'>Details ...</a></td><td>158</td><td>0.34</td><td>1.77</td><td>0.000</td><td>0.012</td><td>0.017</td><td>2138</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_KRAS_SIGNALING_UP'>HALLMARK_KRAS_SIGNALING_UP</a></td><td><a href='HALLMARK_KRAS_SIGNALING_UP.html'>Details ...</a></td><td>141</td><td>0.32</td><td>1.64</td><td>0.000</td><td>0.021</td><td>0.041</td><td>2780</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ANGIOGENESIS'>HALLMARK_ANGIOGENESIS</a></td><td><a href='HALLMARK_ANGIOGENESIS.html'>Details ...</a></td><td>25</td><td>0.46</td><td>1.60</td><td>0.029</td><td>0.027</td><td>0.065</td><td>64</td><td>tags=16%, list=0%, signal=16%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_TGF_BETA_SIGNALING'>HALLMARK_TGF_BETA_SIGNALING</a></td><td><a href='HALLMARK_TGF_BETA_SIGNALING.html'>Details ...</a></td><td>51</td><td>0.33</td><td>1.38</td><td>0.059</td><td>0.131</td><td>0.330</td><td>1591</td><td>tags=24%, list=11%, signal=26%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ANDROGEN_RESPONSE'>HALLMARK_ANDROGEN_RESPONSE</a></td><td><a href='HALLMARK_ANDROGEN_RESPONSE.html'>Details ...</a></td><td>86</td><td>0.29</td><td>1.38</td><td>0.022</td><td>0.114</td><td>0.336</td><td>1464</td><td>tags=24%, list=10%, signal=27%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UV_RESPONSE_DN'>HALLMARK_UV_RESPONSE_DN</a></td><td><a href='HALLMARK_UV_RESPONSE_DN.html'>Details ...</a></td><td>127</td><td>0.27</td><td>1.37</td><td>0.006</td><td>0.106</td><td>0.352</td><td>2036</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ESTROGEN_RESPONSE_LATE'>HALLMARK_ESTROGEN_RESPONSE_LATE</a></td><td><a href='HALLMARK_ESTROGEN_RESPONSE_LATE.html'>Details ...</a></td><td>133</td><td>0.27</td><td>1.35</td><td>0.020</td><td>0.114</td><td>0.414</td><td>2693</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HYPOXIA'>HALLMARK_HYPOXIA</a></td><td><a href='HALLMARK_HYPOXIA.html'>Details ...</a></td><td>160</td><td>0.25</td><td>1.30</td><td>0.021</td><td>0.150</td><td>0.541</td><td>2557</td><td>tags=28%, list=18%, signal=33%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ESTROGEN_RESPONSE_EARLY'>HALLMARK_ESTROGEN_RESPONSE_EARLY</a></td><td><a href='HALLMARK_ESTROGEN_RESPONSE_EARLY.html'>Details ...</a></td><td>140</td><td>0.24</td><td>1.23</td><td>0.061</td><td>0.224</td><td>0.721</td><td>1524</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_XENOBIOTIC_METABOLISM'>HALLMARK_XENOBIOTIC_METABOLISM</a></td><td><a href='HALLMARK_XENOBIOTIC_METABOLISM.html'>Details ...</a></td><td>132</td><td>0.24</td><td>1.20</td><td>0.101</td><td>0.251</td><td>0.791</td><td>1728</td><td>tags=23%, list=12%, signal=27%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_INFLAMMATORY_RESPONSE'>HALLMARK_INFLAMMATORY_RESPONSE</a></td><td><a href='HALLMARK_INFLAMMATORY_RESPONSE.html'>Details ...</a></td><td>133</td><td>0.24</td><td>1.17</td><td>0.085</td><td>0.287</td><td>0.849</td><td>2557</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_INTERFERON_ALPHA_RESPONSE'>HALLMARK_INTERFERON_ALPHA_RESPONSE</a></td><td><a href='HALLMARK_INTERFERON_ALPHA_RESPONSE.html'>Details ...</a></td><td>86</td><td>0.25</td><td>1.17</td><td>0.172</td><td>0.270</td><td>0.854</td><td>2524</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_JUNCTION'>HALLMARK_APICAL_JUNCTION</a></td><td><a href='HALLMARK_APICAL_JUNCTION.html'>Details ...</a></td><td>136</td><td>0.21</td><td>1.07</td><td>0.256</td><td>0.448</td><td>0.964</td><td>1269</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_IL2_STAT5_SIGNALING'>HALLMARK_IL2_STAT5_SIGNALING</a></td><td><a href='HALLMARK_IL2_STAT5_SIGNALING.html'>Details ...</a></td><td>158</td><td>0.20</td><td>1.05</td><td>0.312</td><td>0.482</td><td>0.979</td><td>1562</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>17</td><td><a href='http://cancerimmunity.org/peptide/overexpressed/'>CANCER_IMMUNITY_ANTIGENS_OVEREXPRESSED_IN_TUMORS</a></td><td><a href='CANCER_IMMUNITY_ANTIGENS_OVEREXPRESSED_IN_TUMORS.html'>Details ...</a></td><td>27</td><td>0.28</td><td>1.04</td><td>0.385</td><td>0.469</td><td>0.981</td><td>1646</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HEDGEHOG_SIGNALING'>HALLMARK_HEDGEHOG_SIGNALING</a></td><td><a href='HALLMARK_HEDGEHOG_SIGNALING.html'>Details ...</a></td><td>24</td><td>0.29</td><td>1.03</td><td>0.375</td><td>0.469</td><td>0.987</td><td>353</td><td>tags=8%, list=3%, signal=9%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_FATTY_ACID_METABOLISM'>HALLMARK_FATTY_ACID_METABOLISM</a></td><td><a href='HALLMARK_FATTY_ACID_METABOLISM.html'>Details ...</a></td><td>128</td><td>0.19</td><td>0.96</td><td>0.572</td><td>0.626</td><td>0.998</td><td>1646</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APOPTOSIS'>HALLMARK_APOPTOSIS</a></td><td><a href='HALLMARK_APOPTOSIS.html'>Details ...</a></td><td>142</td><td>0.18</td><td>0.96</td><td>0.548</td><td>0.612</td><td>0.998</td><td>2005</td><td>tags=20%, list=14%, signal=24%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_SPERMATOGENESIS'>HALLMARK_SPERMATOGENESIS</a></td><td><a href='HALLMARK_SPERMATOGENESIS.html'>Details ...</a></td><td>64</td><td>0.20</td><td>0.89</td><td>0.721</td><td>0.742</td><td>1.000</td><td>2866</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>22</td><td><a href='http://cancerimmunity.org/peptide/differentiation/'>CANCER_IMMUNITY_DIFFERENTIATION_ANTIGENS</a></td><td><a href='CANCER_IMMUNITY_DIFFERENTIATION_ANTIGENS.html'>Details ...</a></td><td>1</td><td>0.62</td><td>0.83</td><td>0.765</td><td>0.835</td><td>1.000</td><td>5275</td><td>tags=100%, list=38%, signal=161%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>pre-benefit (4 samples)<b>&nbsp<a href='gsea_report_for_pre-benefit_1440186878769.xls'>[plain text format]</a></caption></table></div><br></body></html>